This presentation focuses on the unique psychosocial complications related to being diagnosed with - and treated for - cancer during the COVID pandemic.

Daniel Richardson, MD, MA, MSc, will explore best practices to approach the care of older adults with leukemia. He will also discuss novel therapeutic options for patients with acute lymphoblastic and acute myeloid leukemia alongside practical considerations to approach shared decision-making.

Immunotherapy has made tremendous progress as cancer-directed therapy has evolved, particularly in the field of T cell-engaging therapies. Common and serious side effects of these types of therapies include Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS). Join us as Bejal Kikani, MSN, FNP-BC, WHNP-BC, discusses the recognition, grading, and treatment of these toxicities.

Arthur Blackstock, Jr., MD, will discuss protons entering the state, the expanded use of Stereotactic Body Radiation Therapy (SBRT), and perhaps review the impact of PSMA imaging in Radiation Oncology.